Suppression of insulin release by calcium antagonist in human insulinoma in vivo and in vitro: its possible role for clinical use.
作者信息
Murakami K, Taniguchi H, Kobayashi T, Seki M, Oimomi M, Baba S
出版信息
Kobe J Med Sci. 1979 Dec;25(4):237-47.
PMID:230384
Abstract
摘要
相似文献
1
2
3
Calcium antagonist (diltiazem) for reversal of hypoglycaemic symptoms in insulinoma.
Lancet. 1977 Sep 3;2(8036):501. doi: 10.1016/s0140-6736(77)91619-1.
4
Absence of insulin release in response to calcium in a patient with a benign insulinoma.一名患有良性胰岛素瘤的患者对钙无胰岛素释放反应。
Horm Metab Res. 1981 Apr;13(4):237-8. doi: 10.1055/s-2007-1019231.
5
Role of calcium in defective insulin secretion from human and transplantable rat islet cell tumours.钙在人及可移植大鼠胰岛细胞瘤胰岛素分泌缺陷中的作用
Biomed Biochim Acta. 1985;44(1):71-5.
6
Lack of suppression of insulin secretion by exercise in patients with insulinoma.胰岛素瘤患者运动时胰岛素分泌缺乏抑制。
Clin Endocrinol (Oxf). 1981 Oct;15(4):391-4. doi: 10.1111/j.1365-2265.1981.tb00679.x.
7
[Pancreatic tumor with endocrinic function].
Geka Chiryo. 1969 Jul;21(1):92-8.
8
Inhibition of insulin release by diphenylhydantoin and diazoxide in a patient with benign insulinoma.苯妥英钠和二氮嗪对一名良性胰岛素瘤患者胰岛素释放的抑制作用
Lancet. 1973 Jan 6;1(7793):40-1. doi: 10.1016/s0140-6736(73)91251-8.
9
Proinsulin and insulin release with a human insulinoma and adjacent nonadenomatous pancreas.人胰岛素瘤及相邻非腺瘤性胰腺中的胰岛素原和胰岛素释放情况。
J Clin Endocrinol Metab. 1973 May;36(5):978-87. doi: 10.1210/jcem-36-5-978.
10
C-peptide suppression test for insulinoma.胰岛素瘤的C肽抑制试验。
J Lab Clin Med. 1977 Jul;90(1):180-6.
Zotero 插件